Member insight: How femtech is breaking the silence on women’s he
By building technology that puts women’s health front and centre, the femtech industry is giving millions of people the language, the data and the confidence to start conversations they were never encouraged to have before.
We asked the founders, executives and innovators driving this space one question: what role do you think femtech plays in destigmatising conversations around women’s health?
Here’s what they had to say.
Joanna Magaji, project director, Women’s HealthX
Femtech is creating a space where women feel more empowered to speak openly about their health and take ownership of their wellbeing.
Topics like menstrual, reproductive, and sexual health have traditionally been surrounded by stigma, making them difficult for many women to discuss.
By developing technology that normalise these conversations and address concerns that often go unspoken, as well as creating accessible at‑home diagnostic tools that allow women to manage aspects of their health privately and confidently, femtech helps break down these barriers.
It not only increases access to information but also fosters a sense of safety, autonomy, and community, all of which play a key role in destigmatising women’s health.
Melissa Wallace, CEO and founding partner, Fierce Foundry
We’re finally seeing FemTech expand beyond fertility and menstruation into historically overlooked areas of women’s health, backed by research we can act on.
For example, new platforms focused on menopause care and cardiovascular diagnostics designed specifically for women.
As founders, investors, researchers, and clinicians collaborate, visibility is accelerating and long-silenced topics are entering mainstream health and technology conversations.
That collective momentum is shifting femtech from a niche category into real infrastructure for cultural and clinical change where evidence replaces stigma, innovation replaces neglect, and women’s health will one day be treated as a standard priority rather than a whispered side conversation.
Diane Wrightson, chief operating officer, Women As One
Femtech puts a spotlight on women’s health and creates a space for conversation, investment, and action. Women’s health is human health, and this has often been forgotten.
Now we have a vehicle to drive action and that’s important to seeing real systematic change in the space.
Wolfgang Hackl MD, CEO of OncoGenomX
FemTech has already transformed how we talk about women’s health, and digital tools have moved breast and gynecologic cancer care from episodic, clinician-led encounters to more continuous, patient-reported, data-driven models—making symptoms, sexual health, and survivorship concerns more visible and discussable.
Clearly, this visibility has helped normalise conversations once considered taboo and strengthened patient agency.
Yet more is needed. Many tools lack robust validation, equitable access remains uneven, and integration into routine oncology workflows is incomplete.
The next step is combining digital engagement with clinically rigorous, genomics informed and evidence-based prediction, ensuring de-stigmatization is matched by accuracy, equity, and reliability.
Daniela Schardinger, CEO & founder, ELAFY Consulting
Femtech plays a critical role in destigmatising women’s health, but only if we move beyond pink marketing without clinical substance.
True destigmatisation requires evidence, regulatory rigor, and sustained investment. Otherwise, we risk replacing silence with noise, and speaking mainly to ourselves within the ecosystem.
The companies that will truly shift the conversation are those building data-backed, scalable solutions for conditions that have historically been underfunded and underdiagnosed.
The ultimate goal is not to preserve the label “femtech,” but to reach a point where women’s health is fully integrated into mainstream indications, research, and reimbursement.
Only then have we truly won.
Chaitra Vedullapalli, founder and president, Women in Cloud
Femtech is redefining executive functioning as a measurable, manageable leadership asset.
For decades, cognitive shifts tied to hormones, inflammation, sleep, and metabolic health were dismissed as stress or burnout.
Today, biomarker testing, cycle intelligence, and AI-driven health platforms are turning invisible strain into actionable data.
This shift destigmatises conversations around focus, memory, and emotional regulation especially during perimenopause and high-pressure leadership phases.
Executive performance is not just about mindset; it’s biological.
When women gain access to predictive health intelligence, they protect cognitive capacity, extend career longevity, and lead with clarity.
Femtech isn’t just advancing health it’s safeguarding economic leadership.
